The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis.

Recent advances in molecular biology have characterised a new class of chloride channels (CLCs) that are referred to as voltage-gated CLCs. To date nine such voltage-gated CLCs (CLC-1 to CLC-7, CLC-Ka and CLC-Kb, which are encoded by the genes CLCN1 to CLCN7, CLC-Ka and CLC-Kb, respectively) have be...

Full description

Bibliographic Details
Main Author: Thakker, R
Format: Journal article
Language:English
Published: 1998
_version_ 1826271174848413696
author Thakker, R
author_facet Thakker, R
author_sort Thakker, R
collection OXFORD
description Recent advances in molecular biology have characterised a new class of chloride channels (CLCs) that are referred to as voltage-gated CLCs. To date nine such voltage-gated CLCs (CLC-1 to CLC-7, CLC-Ka and CLC-Kb, which are encoded by the genes CLCN1 to CLCN7, CLC-Ka and CLC-Kb, respectively) have been identified in mammals. Mutations in two of these, CLC-5 and CLC-Kb, have been defined in the hypercalciuric nephrolithiasis disorders of Dent's disease and a form of Bartter's syndrome, respectively. In addition, other forms of Bartter's syndrome have been defined with mutations involving the bumetanide-sensitive sodium-potassium-chloride cotransporter (NKCC2) and the potassium channel ROMK. Finally, mutations of the thiazide-sensitive sodium-chloride cotransporter (NCCT) are associated with Gitelman's syndrome, in which hypocalciuria and hypomagnesaemia are notable features. These molecular genetic studies have increased our understanding of the renal tubular mechanisms that regulate mineral homeostasis.
first_indexed 2024-03-06T21:52:30Z
format Journal article
id oxford-uuid:4bc9a6db-e2c8-4f6f-b08e-cad99c5e9de4
institution University of Oxford
language English
last_indexed 2024-03-06T21:52:30Z
publishDate 1998
record_format dspace
spelling oxford-uuid:4bc9a6db-e2c8-4f6f-b08e-cad99c5e9de42022-03-26T15:45:37ZThe role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4bc9a6db-e2c8-4f6f-b08e-cad99c5e9de4EnglishSymplectic Elements at Oxford1998Thakker, RRecent advances in molecular biology have characterised a new class of chloride channels (CLCs) that are referred to as voltage-gated CLCs. To date nine such voltage-gated CLCs (CLC-1 to CLC-7, CLC-Ka and CLC-Kb, which are encoded by the genes CLCN1 to CLCN7, CLC-Ka and CLC-Kb, respectively) have been identified in mammals. Mutations in two of these, CLC-5 and CLC-Kb, have been defined in the hypercalciuric nephrolithiasis disorders of Dent's disease and a form of Bartter's syndrome, respectively. In addition, other forms of Bartter's syndrome have been defined with mutations involving the bumetanide-sensitive sodium-potassium-chloride cotransporter (NKCC2) and the potassium channel ROMK. Finally, mutations of the thiazide-sensitive sodium-chloride cotransporter (NCCT) are associated with Gitelman's syndrome, in which hypocalciuria and hypomagnesaemia are notable features. These molecular genetic studies have increased our understanding of the renal tubular mechanisms that regulate mineral homeostasis.
spellingShingle Thakker, R
The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis.
title The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis.
title_full The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis.
title_fullStr The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis.
title_full_unstemmed The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis.
title_short The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis.
title_sort role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis
work_keys_str_mv AT thakkerr theroleofrenalchloridechannelmutationsinkidneystonediseaseandnephrocalcinosis
AT thakkerr roleofrenalchloridechannelmutationsinkidneystonediseaseandnephrocalcinosis